By Laura Dyrda A new report from MarketsandMarkets shows the spinal biologics market is expected to grow over the next five years. Here are five key notes: 1. The market was valued at $1.9 billion in 2014 and expected to grow at
All News
St. Jude Medical (NYSE: STJ) announced the European launch of the Proclaim Elite Spinal Cord Stimulation System, the first and only upgradeable and non-rechargeable spinal cord stimulation (SCS) system approved to deliver burst stimulation from St. Jude Medical. The approval also
By Melissa Jacobs Sept. 30, 2015, was the fourth opening day of Dr. Jill Cohen’s practice. The first was in 1997, when she joined Great Valley Medical Associates, a seven-partner primary-care practice in Paoli. Then that practice became Great Valley Health, after
By Casey Tingle Investigators discovered no significant difference in clinical outcomes at 2 years among patients with non-traumatic supraspinatus shoulder tears who were treated with either physiotherapy only, acromioplasty and physiotherapy, or rotat…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today announced the appointment of Jay Blackington as Vice President, Head of Human Resources. Mr. Blackington most recently was Senior Vice President, Global Human Resources at the Avid Corporation, a leading global provider of
By Laura Dyrda Treating back pain and other spinal conditions can cost more than $200 billion annually in the United States, with $90 billion in direct costs. There are several factors contributing to the ever-increasing cost of care, including hospital
KIRKLAND, QC, Nov. 24, 2015 /CNW Telbec/ – Ortho Regenerative Technologies Inc. (“Ortho RTi”), a Canadian orthopaedic biotechnology company, announced today that it has filed a preliminary prospectus with the securities regulatory authorities of all provinces and territories in Canada. The non-financing prospectus was
AccelSPINE, a Dallas-based medical device designer, recently announced it has received CE marking and European ISO 13485 certification. AccelSPINE’s CE marking allows the company to expand its customer base to the European Union and the five additional countries that adhere to
INDIANAPOLIS–(BUSINESS WIRE)–Active Implants, a company that develops orthopedic implant solutions, today announced that the company’s VENUS (Verification of the Effectiveness of the NUsurface® System) trial is now underway at OrthoIndy in Indianapolis. OrthoIndy is the only center in the state
© 2025 MedDeviceJobs.com Powered by Careerleaf
v.4.6.1